Tag: immunobridging
-
FDA Determines COVID-19 Vaccine of Limited Benefit to General Population
by James Lyons-Weiler, PhD, Popular Rationalism, ©2025 (Jul. 13, 2025) — Washington, D.C. — July 2025. According to CBS News, members of the US Health and Human Services administration “overrode career staff at the agency to limit the approvals of COVID-19 shots from Novavax and Moderna”. On May 16, 2025, the U.S. Food and Drug Administration…
-
Why the FDA’s Delay of Pfizer’s EUA for Children is Catastrophic for Vaccines
by John Anthony, Sustainable Freedom Lab, ©2022 (Feb. 12, 2022) — On Feb 11, the FDA made the shocking announcement they are postponing the Advisory Committee meeting to approve the EUA for Pfizer’s vaccines for children 6 months to 4 years of age. The press dutifully repeated the official release explaining that more testing is…